| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ENERGY TRANSFER PRTNRS L P | 261,222 | 9,945,000 | 7.38% | ||
| 2 | WILLIAMS PARTNERS L P NEW | 236,361 | 8,188,000 | 6.08% | ||
| 3 | SUNOCO LOGISTICS PRTNRS L P | 232,999 | 6,699,000 | 4.97% | ||
| 4 | BUCKEYE PARTNERS L P UNIT LTD PARTN | 85,491 | 6,013,000 | 4.46% | ||
| 5 | MPLX LP | 170,189 | 5,723,000 | 4.25% | ||
| 6 | ENBRIDGE ENERGY PARTNERS L P | 231,210 | 5,364,000 | 3.98% | ||
| 7 | WILLIAMS COS INC DEL | 227,215 | 4,915,000 | 3.65% | ||
| 8 | MAGELLAN MIDSTREAM PRTNRS LP | 60,029 | 4,562,000 | 3.39% | ||
| 9 | ENERGY TRANSFER L P | 311,573 | 4,477,000 | 3.32% | ||
| 10 | ENTERPRISE PRODS PARTNERS L | 152,424 | 4,460,000 | 3.31% | ||
| 11 | ONEOK PARTNERS LP | 103,206 | 4,134,000 | 3.07% | ||
| 12 | PLAINS ALL AMERN PIPELINE L | 141,065 | 3,878,000 | 2.88% | ||
| 13 | TESORO LOGISTICS LP | 76,763 | 3,802,000 | 2.82% | ||
| 14 | ENLINK MIDSTREAM PARTNERS LP | 202,717 | 3,371,000 | 2.50% | ||
| 15 | EQT MIDSTREAM PARTNERS LP | 41,252 | 3,313,000 | 2.46% | ||
| 16 | WESTERN GAS PARTNERS LP | 50,552 | 2,548,000 | 1.89% | ||
| 17 | GENESIS ENERGY LP COM UNITS NPV | 62,485 | 2,398,000 | 1.78% | ||
| 18 | CRESTWOOD EQUITY PARTNERS LP | 116,237 | 2,343,000 | 1.74% | ||
| 19 | PHILLIPS 66 PARTNERS LP | 35,654 | 1,992,000 | 1.48% | ||
| 20 | NGL Energy Partners LP | 77,428 | 1,496,000 | 1.11% | ||
| 21 | DCP MIDSTREAM LP | 38,886 | 1,341,000 | 1.00% | ||
| 22 | TESARO INC | 13,178 | 1,108,000 | 0.82% | ||
| 23 | TARGA RES CORP | 25,563 | 1,077,000 | 0.80% | ||
| 24 | TC PIPELINES LP | 15,519 | 889,000 | 0.66% | ||
| 25 | SHELL MIDSTREAM PARTNERS L P | 25,425 | 859,000 | 0.64% | ||
| 26 | WESTERN GAS EQUITY PARTNERS | 20,602 | 788,000 | 0.58% | ||
| 27 | KERYX BIOPHARMACEUTICALS INCORPORATED | 92,536 | 613,000 | 0.45% | ||
| 28 | SPECTRA ENERGY CORP | 16,311 | 597,000 | 0.44% | ||
| 29 | RETROPHIN INC COM | 32,857 | 585,000 | 0.43% | ||
| 30 | EXELIXIS INC | 74,230 | 580,000 | 0.43% | ||
| 31 | IONIS PHARMACEUTICALS INC | 24,345 | 567,000 | 0.42% | ||
| 32 | SEATTLE GENETICS INC | 13,991 | 565,000 | 0.42% | ||
| 33 | VANDA PHARMACEUTICALS INC COM | 50,287 | 563,000 | 0.42% | ||
| 34 | LIGAND PHARMACEUTICALS INC | 4,705 | 561,000 | 0.42% | ||
| 35 | IRONWOOD PHARMACEUTICALS INC COM CL A | 42,277 | 553,000 | 0.41% | ||
| 36 | Theravance Biopharma Inc | 24,323 | 552,000 | 0.41% | ||
| 37 | MEDIVATION INC | 9,058 | 546,000 | 0.41% | ||
| 38 | PDL BIOPHARMA INCORPORATED | 173,837 | 546,000 | 0.41% | ||
| 39 | INTERCEPT PHARMACEUTICAL | 3,826 | 546,000 | 0.41% | ||
| 40 | INCYTE | 6,820 | 545,000 | 0.40% | ||
| 41 | BIOGEN INC | 2,251 | 544,000 | 0.40% | ||
| 42 | GILEAD SCIENCES INC | 6,511 | 543,000 | 0.40% | ||
| 43 | AMGEN INC | 3,557 | 541,000 | 0.40% | ||
| 44 | ACORDA THERAPEUTICS | 21,130 | 539,000 | 0.40% | ||
| 45 | UNITED THERAPEUTICS | 5,073 | 537,000 | 0.40% | ||
| 46 | RAPTOR PHARMACEUTICAL CORP | 99,654 | 535,000 | 0.40% | ||
| 47 | CELGENE CORP | 5,386 | 531,000 | 0.39% | ||
| 48 | HALOZYME THERAPEUTICS INC | 61,274 | 529,000 | 0.39% | ||
| 49 | CROSSTEX ENERGY INC | 33,190 | 528,000 | 0.39% | ||
| 50 | BIOMARIN | 6,713 | 522,000 | 0.39% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-020204, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
